Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
Date:10/23/2007

(45.1) (41.9)

Treasury stock purchases (131.4) (125.0)

Exercise of stock options 24.9 21.1

Excess tax benefits from stock-based

payments 5.5 2.4

Net cash used in financing activities (123.7) (120.0)

Effect of exchange rate changes on cash 8.1 3.7

Net change in cash and cash equivalents 29.0 38.4

Cash and cash equivalents at January 1 173.8 98.6

Cash and cash equivalents at March 31 $202.8 $137.0

SIGMA-ALDRICH CORPORATION

Supplemental Financial Information - (Unaudited)

Sales Growth by Business Unit

Three Months

Ended September 30, 2007

Currency Adjusted

Reported Impact Acquisition (Organic)

Research Essentials 8.6% 4.2% -% 4.4%

Research Specialties 13.6% 4.8% -% 8.8%

Research Biotech 11.2% 4.0% -% 7.2%

SAFC 19.8% 4.0% 9.7% 6.1%

Total 14.0% 4.3% 2.7% 7.0%

Nine Months

Ended September 30, 2007

Currency Adjusted

Reported Impact Acquisition (Organic)

Research Essentials 8.3% 3.9% -% 4.4%

Research Specialties 13.0% 4.4% -% 8.6%

Research Biotech 7.0% 3.6% -% 3.4%

SAFC 20.0% 4.0% 7.5% 8.5%

Total 1
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Jellyfish partners for sales tracking technology
2. Doyle wants sales tax applied to digital downloads
3. Mortgagebot builds online sales even as housing declines
4. Third Wave reports another loss, stronger sales
5. Johnson Controls reports record quarterly sales
6. Can sales outsourcing grow Wisconsin biotechs?
7. Sonic Foundry reports quarterly loss, higher Mediasite sales
8. My-oh, its BIO! Where sales hype and science collide
9. Third Wave shuffles finance, sales management
10. Johnson Controls sales up, profits down
11. Turning ads into sales: Context is king
Post Your Comments:
*Name:
*Comment:
*Email: